| __timestamp | Celldex Therapeutics, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 21954000000 |
| Thursday, January 1, 2015 | 33837000 | 21203000000 |
| Friday, January 1, 2016 | 35979000 | 19945000000 |
| Sunday, January 1, 2017 | 25003000 | 21420000000 |
| Monday, January 1, 2018 | 19269000 | 22540000000 |
| Tuesday, January 1, 2019 | 15426000 | 22178000000 |
| Wednesday, January 1, 2020 | 14456000 | 22084000000 |
| Friday, January 1, 2021 | 20488000 | 20118000000 |
| Saturday, January 1, 2022 | 27195000 | 19046000000 |
| Sunday, January 1, 2023 | 30914000 | 20112000000 |
| Monday, January 1, 2024 | 21969000000 |
Data in motion
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Johnson & Johnson, a global healthcare giant, and Celldex Therapeutics, a smaller biotech firm, offer contrasting approaches. From 2014 to 2023, Johnson & Johnson consistently maintained SG&A expenses around $21 billion annually, showcasing a stable cost management strategy. In contrast, Celldex Therapeutics, with a more volatile expense pattern, saw a 50% increase in SG&A costs from 2014 to 2023, peaking at $31 million. This disparity highlights the challenges smaller firms face in scaling operations while managing costs. Johnson & Johnson's ability to keep expenses steady despite market fluctuations underscores its robust financial strategies. As the industry evolves, these insights into SG&A management could guide emerging biotech firms in optimizing their financial health.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Neurocrine Biosciences, Inc.
Breaking Down SG&A Expenses: Johnson & Johnson vs Biogen Inc.
Breaking Down SG&A Expenses: Johnson & Johnson vs Insmed Incorporated
Johnson & Johnson or Bio-Techne Corporation: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Johnson & Johnson vs Blueprint Medicines Corporation
Comparing SG&A Expenses: Johnson & Johnson vs Apellis Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Johnson & Johnson vs Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and Wave Life Sciences Ltd.
AstraZeneca PLC and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Insmed Incorporated vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Walgreens Boots Alliance, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Perrigo Company plc vs Celldex Therapeutics, Inc. Trends and Insights